Stay updated on Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2; removed the Back to Top link.
    Difference
    0.2%
    Check dated 2025-09-13T17:38:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:20:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations across various countries, as well as updated drug information for several medications. Notably, the drug information for Nivolumab has been expanded to include Paclitaxel and Ramucirumab, while the previous mention of Relatlimab has been removed.
    Difference
    11%
    Check dated 2025-08-30T11:57:36.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:43:17.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T00:03:31.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-01T19:29:27.000Z thumbnail image

Stay in the know with updates to Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.